This provider's $7.9M in total Medicare payments ranks in the 88th percentile of Clinical Laboratory providers nationally.
Their average markup ratio of 8.92x is significantly above the specialty median of 3.7x.
Medicare payments to this provider grew 2380% from 2016 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 562% in 2019
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2016 | $9.9K | $203.58 | 48.63x | $9.7K | $65.8K | 323 | 166 |
| 2017 | $5.4K | $156.90 | 34.40x | $5.2K | $144.0K | 1.0K | 482 |
| 2018 | $242.09 | $86.93 | 2.78x | $155.16 | $105.2K | 1.1K | 950 |
| 2019 | $175.78 | $84.38 | 2.08x | $91.40 | $696.3K | 11.6K | 6.5K |
| 2020 | $69.47 | $30.32 | 2.29x | $39.15 | $1.8M | 42.2K | 25.0K |
| 2021 | $88.06 | $17.40 | 5.06x | $70.66 | $1.8M | 79.4K | 37.5K |
| 2022 | $112.54 | $25.55 | 4.40x | $86.99 | $1.7M | 87.5K | 40.4K |
| 2023 | $67.75 | $21.87 | 3.10x | $45.88 | $1.6M | 88.4K | 48.9K |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 23.9K | $2.0M | $83.39 | 19.71x |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 3.2K | $625.8K | $195.26 | 3.05x |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within | 18.6K | $461.7K | $24.85 | 21.12x |
| 87502 | Detection test by nucleic acid for multiple types influenza virus | 4.3K | $404.1K | $93.86 | 3.19x |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 16.8K | $391.0K | $23.29 | 1.40x |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | 34.1K | $351.7K | $10.32 | 1.54x |
| 87798 | Detection test for organism | 6.9K | $246.2K | $35.80 | 1.91x |
| 80053 | Blood test, comprehensive group of blood chemicals | 22.7K | $235.6K | $10.36 | 2.73x |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | 13.5K | $223.9K | $16.57 | 2.65x |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 3.0K | $217.5K | $73.44 | 3.40x |
| 87150 | Identification of organisms by genetic analysis | 6.0K | $214.2K | $35.96 | 1.81x |
| 82306 | Vitamin d-3 level | 6.0K | $174.0K | $29.14 | 3.08x |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test | 22.5K | $173.7K | $7.72 | 3.06x |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | 11.7K | $154.1K | $13.20 | 3.27x |
| 87633 | Detection test for multiple types of respiratory virus | 368 | $152.0K | $412.97 | 1.87x |
| G0483 | Drug test def 22+ classes | 647 | $143.7K | $222.05 | 34.51x |
| 36415 | Insertion of needle into vein for collection of blood sample | 29.0K | $140.5K | $4.85 | 4.09x |
| 82607 | Cyanocobalamin (vitamin b-12) level | 9.2K | $137.2K | $14.89 | 3.06x |
| 87481 | Detection test for candida species (yeast) | 3.6K | $125.9K | $34.95 | 1.86x |
| 87653 | Detection test for strep (streptococcus, group b) | 3.6K | $125.7K | $34.95 | 1.86x |
This provider submits charges 8.92 times higher than what Medicare actually pays.
A markup ratio of 8.92x means for every $100 Medicare pays, this provider initially charges $892. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Clinical Laboratory providers in FL for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Quest Diagnostics Clinical Laboratories Inc | Tampa, FL | $1.0B | ⚠️ Flagged |
| Laboratory Corporation Of America | Tampa, FL | $463.1M | ⚠️ Flagged |
| Quest Diagnostics Clinical Laboratories Inc | Miramar, FL | $417.1M | ⚠️ Flagged |
| American Health S, Llc | Davie, FL | $175.7M | ✓ Clear |
| Ameripath Florida Llc | Pompano Beach, FL | $80.1M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data